​At Vanquish Bio, we envision a future where the deadliest and most treatment-resistant diseases are no longer a life sentence. Through bold science and transformative biologics, we are committed to conquering cancer and other intractable conditions—empowering patients with hope, health, and time.

​

• Novel, first-in-class natural killer derived extracellular vesicles as a new treatment against cancers

• Seed funding by National Cancer Institute

• Effective, Low Risk, Non-Toxic and Affordable

• Better Outcomes Low Capital and Operational

• Highly Accessible

• Reduced Drug Amounts in Body, and Reduced Shelf Space

• Easy to Ship and Store

• Long Shelf Life